SCHEMBL13840344

SCHEMBL13840344

CCN1C(=O)N(CC)C(C)C1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.52
F2 P00734 1/20 0.43
ELANE P08246 1/20 0.43
CTSG P08311 1/20 0.43
CTRC Q99895 1/20 0.43
GAA P10253 2/20 0.39
TP53 P04637 1/20 0.34
MEN1 O00255 1/20 0.33
PABPC1 P11940 1/20 0.33
KMT2A Q03164 1/20 0.33
GBA1 P04062 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 2/20 0.32
GMNN O75496 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
THPO P40225 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12211798 0.79 L3MBTL1 (0.76) L3MBTL1F2ELANECTSGCTRC
SCHEMBL20198794 0.79 L3MBTL1 (0.76) L3MBTL1F2ELANECTSGCTRC
SCHEMBL26377007 0.76 L3MBTL1 (0.46) L3MBTL1F2ELANECTSGCTRC
SCHEMBL12418938 0.74 L3MBTL1 (0.56) L3MBTL1MEN1PABPC1KMT2AGBA1
SCHEMBL8434874 0.74 L3MBTL1 (0.56) L3MBTL1F2ELANECTSGCTRC
SCHEMBL19959610 0.73 L3MBTL1 (0.36) L3MBTL1
SCHEMBL16451539 0.71 L3MBTL1 (0.34) L3MBTL1
SCHEMBL13492923 0.71 L3MBTL1 (0.41) L3MBTL1F2ELANECTSGCTRC
SCHEMBL2742285 0.70 L3MBTL1 (0.32) L3MBTL1MEN1PABPC1KMT2ALMNA
SCHEMBL13058043 0.69 KDM4E (0.33) L3MBTL1GAATP53GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531008-B2 Use of at least one cationic cyanin derivative for dyeing the hair, composition containing it, process for treating keratin fibers using the composition, and device therefor L'OREAL S.A. (FR) 2009-05-12 US disclosed
US-7427301-B2 Composition comprising at least one substituted carbocyanin derivative, process for treating keratin fibers using it, device therefor and use thereof L'ORéAL S.A. (FR) 2008-09-23 US disclosed
US-7425221-B2 Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use L'OREAL S.A. (FR) 2008-09-16 US disclosed
US-7419511-B2 Compositions comprising at least one substituted carbocyanin derivative, processes for treating keratin fibers using them, device therefor and uses thereof L'OREAL, S.A. (FR) 2008-09-02 US disclosed
US-7377946-B2 Composition comprising at least one substituted 2-[2-(4-amino phenyl)ethenyl]-1-pyridinium derivative, process for treating keratin fibres using it, device and use thereof L'ORÉAL (FR) 2008-05-27 US disclosed
US-20070143936-A1 Use of at least one cationic cyanin derivative for dyeing the hair, composition containing it, process for treating keratin fibers using the composition, and device therefor L'OREAL S.A. (FR) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070143936-A1 Use of at least one cationic cyanin derivative for dyeing the hair, composition containing it, process for treating keratin fibers using the composition, and device therefor KRT18, HKDC1, DSC1 L3MBTL1 4631/4885F2 1958/4885ELANE 3110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.